12 / 23
Pharmacognosy 2019
March 11-12, 2019
London, UK
American Journal of Ethnomedicine
ISSN: 2348-9502
Page 49
Pharmacognosy and
Medicinal Plants
7
th
Edition of International Conference on
Am J Ethnomed 2019, Volume 6
DOI: 10.21767/2348-9502-C1-009
Clinical trial of herbal treatment gene
Eden-Vir/Novirin
in
oral herpes
Hanan Polansky, Adrian Javaherian
and
Edan Itzkovitz
Centre for the Biology of Chronic Disease, USA
O
ur previous articles showed that suppressive or
preventive treatment with the herbal gene-
Eden-
VIR/Novirin
reduced the number and duration of genital
herpes outbreaks with no adverse effects. These studies
also revealed that the herbal gene-
Eden-VIR/Novirin
is
mostly superior to acyclovir, valacyclovir and famciclovir
drugs in genital herpes. This study tested the effect of
gene
Eden-VIR/Novirin
in oral herpes also called cold
sores and fever blisters.
Methods:
The framework of the studywas a retrospective
chart review. The study included 68 participants. The
participants took 1 to 4 capsules per day over a period
of 2 to 36 months. The study included two Food and drug
administration recommended controls: baseline and a no
treatment.
Results:
Gene
Eden-VIR/Novirin
was effective in 89.3%
of participants. The treatment reduced the mean number
of outbreaks per year from 6.0 and 3.6 in the control
groups to 2.0 in the treatment group (P<.0001 and P=.07,
respectively). Gene-
Eden-VIR/Novirin
reduced the mean
duration of outbreaks from9.8 and 5.8 days in the control
groups to 3.2 days in the treatment group (P<.0001 and
P=.02, respectively). There were no reports of adverse
experiences. Gene-
Eden-VIR/Novirin
was compared to
acyclovir and valacyclovir in 6 tests. In all tests, Gene
Eden-VIR/Novirin
showed higher efficacy. Gene
Eden-VIR/
Novirin
also showed superior safety.
Conclusions:
This clinical study showed that suppressive
or preventive treatment with the herbal gene
Eden-VIR/
Novirin
reduced the number and duration of outbreaks
in oral herpes without any adverse effects. The study
also showed that the herbal gene
Eden-VIR/Novirin
had
better clinical effects than acyclovir and valacyclovir, the
leading drugs in the category. Based on these results, we
recommend using the herbal gene
Eden-VIR/Novirin
as
preventive treatment for oral herpes and specifically as
an alternative to the acyclovir and valacyclovir drugs